From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis

被引：4
|
作者：
Thatcher, Thomas H. [1 ]
Peters-Golden, Marc [2 ]
机构：
[1] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA
[2] Univ Michigan, Med Sch, Dept Internal Med, Ann Arbor, MI USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 206卷 / 05期
关键词：
THROMBOXANE A(2); RECEPTOR;
D O I：
10.1164/rccm.202205-0914ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：530 / 532
页数：4
相关论文
共 50 条
  • [11] F2-Isoprostanes and Adiposity in Older Adults
    Kanaya, Alka M.
    Wassel, Christina L.
    Stoddard, Pamela J.
    Harris, Tamara B.
    Cummings, Steven R.
    Kritchevsky, Stephen B.
    Goodpaster, Bret H.
    Green, Christie
    Satterfield, Suzanne
    Gross, Myron D.
    OBESITY, 2011, 19 (04) : 861 - 867
  • [12] F2-Isoprostanes, tocopherols and normal pregnancy
    Palm, Maria
    Axelsson, Ove
    Wernroth, Lisa
    Basu, Samar
    FREE RADICAL RESEARCH, 2009, 43 (06) : 546 - 552
  • [13] F2-isoprostanes:: Review of analytical methods
    Berdeaux, O
    Scruel, O
    Cracowski, JL
    Durand, T
    CURRENT PHARMACEUTICAL ANALYSIS, 2006, 2 (01) : 69 - 78
  • [14] F2-Isoprostanes and Adiposity in Older Adults
    Kanayk, Alka M.
    Wassel, Christina L.
    Harris, Tamara
    Cummings, Steven R.
    Kritchevsky, Steve
    Goodpaster, Bret
    Satter-Field, Suzanne
    Gross, Myron
    DIABETES, 2009, 58 : A256 - A256
  • [15] Elevated F2-isoprostanes in thalassemic patients
    Matayatsuk, Chutima
    Lee, Chung-Yung J.
    Kalpravidh, Ruchaneekorn W.
    Sirankapracha, Pornpan
    Wilairat, Prapin
    Fucharoen, Suthat
    Halliwell, Barry
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 (12) : 1649 - 1655
  • [16] Antioxidant supplementation decreases lipid peroxidation biomarker F2-isoprostanes in plasma of smokers
    Dietrich, M
    Block, G
    Hudes, M
    Morrow, JD
    Norkus, EP
    Traber, MG
    Cross, CE
    Packer, L
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (01) : 7 - 13
  • [17] Independent Association of Urinary F2-Isoprostanes With Survival in Pulmonary Arterial Hypertension
    Cracowski, Jean-Luc
    Degano, Bruno
    Chabot, Francois
    Labarere, Jose
    Schwedhelm, Edzard
    Monneret, Denis
    Iuliano, Luigi
    Schwebel, Carole
    Chaouat, Ari
    Reynaud-Gaubert, Martine
    Faure, Patrice
    Maas, Renke
    Renversez, Jean-Charles
    Cracowski, Claire
    Sitbon, Olivier
    Yaici, Azzedine
    Simonneau, Gerald
    Humbert, Marc
    CHEST, 2012, 142 (04) : 869 - 876
  • [18] Urinary F2-isoprostanes and the risk of hypertension
    Melton, Charles David
    Luo, Ruiyan
    Wong, Brett J.
    Spasojevic, Ivan
    Wagenknecht, Lynne E.
    D'Agostino, Ralph B., Jr.
    Il'yasova, Dora
    ANNALS OF EPIDEMIOLOGY, 2017, 27 (06) : 391 - 396
  • [19] F2-isoprostanes from arachidonic acid -: Biomarkers of oxidative stress?
    Schmandke, H
    ERNAHRUNGS UMSCHAU, 2000, 47 (05): : 172 - +
  • [20] Urinary F2-isoprostanes formation in kidney transplantation
    Cracowski, JL
    Souvignet, C
    Quirin, N
    Grosbois, X
    Bayle, F
    Stanke-Labesque, F
    Vialtel, P
    Bessard, G
    CLINICAL TRANSPLANTATION, 2001, 15 (01) : 58 - 62
12345